Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fampridine Pregnancy Exposure Registry

NCT01532154 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01532154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01532154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fampridine Pregnancy Exposure Registry
Lead sponsor
Biogen
Phase
Observational
Overall status
Terminated
Start date
August 31, 2015
Completion date
February 29, 2016
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, pregnancy